期刊文献+

谷氨酸脱羧酶抗体在初诊成人2型糖尿病患者中的阳性率及其意义 被引量:1

Diagnostic role of glutamic acid decarboxylase antibody in phenotypic type 2 diabetic patients
下载PDF
导出
摘要 目的探讨谷氨酸脱羧酶抗体(GAD-Ab)在初诊成人2型糖尿病(T2DM)患者中的阳性率以及成人隐匿性自身免疫糖尿病(LADA)的临床特点。方法用放射配体法检测274例临床初诊为T2DM的患者GAD-Ab,分析GAD-Ab的阳性率及其在各个年龄段的分布特点和临床特征。结果①GAD-Ab在初诊T2DM患者的阳性率为6.9%(19/274);②GAD-Ab阳性率在T2DM患者中30~40岁为11.5%,40~50岁为9.1%,50~60岁为4.4%,60~70岁为2.6%;③LADA组与T2DM组在年龄、性别、HbA1c、空腹C肽、GAD-Ab滴度差异有统计学意义(P<0.05),其血脂代谢、体质量指数(BMI)、DM家族史方面相比差异无统计学意义(P>0.05)。结论①GAD-Ab检测可以提高诊断LADA的敏感性;②GAD-Ab的阳性率和滴度水平与糖尿病患者的临床特征有关系。 Objective In clinical practice, Type 1 and Type 2 diabetic patients are sometimes difficult to distinguish. Latent autoimmune diabetes of the adult (LADA) is a subgroup of diabetes, somewhere on the borderland between Type 1 and Type 2 diabetes. It has been reported that some patients with Type 2 diabetes mellitus (T2DM) have LADA and may show different clinical characteristics than those with T2DM. Glutamic acid decarboxylase autoantibodies (GADA) are the best immune marker to identify LADA patients. We aimed to determine the ratio and clinical fea- tures of LADA in patients with diagnosed initially as T2DM and to compare the clinical characteristics between T2DM and LADA with different titers of GADA. Methods 274 patients with an initial diagnosis of T2DM from the Shanxi Province of China were screened for GADA using a radioligand assay. The distribution and frequency of GADA levels were described. Two hundred and seventy-four patients were divided into the T2DM group ( n = 255) and the LADA group (n = 19) to ctmapare the age of onset, ketotic history, body mass index, waist-to-hip ratio, HbAlc, C-peptide, hypertension and dyslipidemia. Furthermore, LADA patients with different GADA titers were subdivided to analyze the same indexes as the above. Results The prevalence of LADA (defined as GADA^0.05, namely GADA positive) was 6.9% in the 274 initially diagnosed type 2 diabetic patients. Compared with T2DM, LADA patients were younger at their ages of onset, had lower C-peptide and body mass index, and also had less cases with hypertension and with dyslipidemia. However, only patients with high titer of GADA(GADA≥0.5) had poorer beta cell functions and less diabetic complications compared to T2DM and low GADA titer (0.05≤GADA〈 0.5)of LADA patients. Patients with low GADA titer were similar to T2DM patients, except that they were prone to develop ketosis more frequently. Conclusion This study indicated that the important portion of the patients who were initially diagnosed as T
出处 《山西医药杂志》 CAS 2007年第11期970-972,共3页 Shanxi Medical Journal
关键词 糖尿病 2型 谷氨酸脱羧酶 抗体 成人隐匿性自身免疫糖尿病 Diabetes mellitus,type 2 Glutamate decarboxylase Antibodies Latent autoimmune diabetes in adults
  • 相关文献

参考文献11

  • 1Tuomi T,Groop LC,Zimmet PZ,et al.Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease.Diabetes,1993,42:359-362. 被引量:1
  • 2周智广,伍汉文.成人隐匿性自身免疫性糖尿病的诊断与治疗[J].中华内分泌代谢杂志,1998,14(1):1-2. 被引量:98
  • 3李霞,周智广,黄干,彭健,颜湘,杨琳,王建平,邓志明.谷氨酸脱羧酶抗体在初诊成人2型糖尿病患者中的阳性率及其分布特点[J].中华流行病学杂志,2005,26(10):800-803. 被引量:9
  • 4李霞,周智广,杨琳,黄干,颜湘.成人隐匿性自身免疫糖尿病与代谢综合征的关系[J].中国医学科学院学报,2003,25(6):676-679. 被引量:20
  • 5Tuomi T,Carlsson A.Li H,et al.Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies.Diabetes,1999,48(1):150-157. 被引量:1
  • 6Zimmet PZ,Elliott RB,Mackay IR,et al.Autoantibodies to glutamic acid decarboxylase and insulin in islet cell antibody positive presymptomatic type 1 diabetes mellitus:frequency and segregation by age and gender.Diabet Med,1994,11(9):866-871. 被引量:1
  • 7Schmidli RS,DeAizpurua HJ,Harrison LC,et al.Antibodies to glutamic acid decarboxylase in at-risk and clinical insulin-dependent diabetic subjects:relationship to age,sex and islet cell antibody,status,and temporal profile.J Autoimmun,1994,7(1):55-66. 被引量:1
  • 8Ahn CW,Kim HS,Nam JH,et al.Clinical characteristics,GAD antibody (GADA) and change of C-peptide in Korean young age of onset diabetic patients.Diabet Med,2002,19(3):227-233. 被引量:1
  • 9Tumer R,Stratton I,Horton V,et al.UKPDS 25:autoantibodies to islet-cell cytoplasm and glutamic acid decarboxylase for prediction of insulin requirement in type 2 diabetes.Lancet,1997,350(9087):1288-1293. 被引量:1
  • 10Takeda H,Kawasaki E,SMmizu I,et al.Clinical,autoimmune,and genetic characteristics of adult-onset diabetic patients with GAD autoantibodies in Japan(Ehime Study).Diabetes Care,2002,25(6):995-1001. 被引量:1

二级参考文献15

  • 1[1]Tuomi T, Groop LC, Zimmet PZ, et al. Antibodies to glutamic acid decarboxylase reveal latent autoimmune diabetes mellitus in adults with a non-insulin-dependent onset of disease. Diabetes, 1993, 42:359-362 被引量:1
  • 2[2]Juneja R, Palmer JP. Type 1.5 Diabetes: myth or reality?Autoimmunity, 1997, 29:65-83 被引量:1
  • 3[3]World Health Organization. Definition, diagnosis, and classification of diabetes mellitus and its complications:report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus. Geneva, Switzerland:World Health Organization, 1999 被引量:1
  • 4[6]Carlsson A, Sundkvist G, Groop L, et al. Insulin and glucagon secretion in patients with slowly progressing autoimmune diabetes (LADA). J Clin Endocrinol Metab,2000, 85:76-80 被引量:1
  • 5[7]Tuomi T, Carlsson A, Li H, et al. Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies. Diabetes, 1999, 48:150-157 被引量:1
  • 6[8]Isomaa B, Almgren P, Tuomi T, et al. Cardiovascular morbidity and mortality associated with the metabolic syndrome. Diabetes Care, 2001, 24:683-689 被引量:1
  • 7[9]Kobayashi T, Maruyama T, Shimada A, et al. Insulin intervention to preserve beta cells in slowly progressive insulindependent (type 1) diabetes mellitus. Ann NY Acad Sci, 2002, 958:117-130 被引量:1
  • 8[10]Dubuquoy L, Bourdon C, Peuchmaur M, et al. Peroxisome proliferator activated receptor (PPAR) gamma: a new target for the treatment of inflammatory bowel disease. Gastroenterol Clin Biol, 2000, 24:719-724 被引量:1
  • 9[11]Beales PE, Pozzilli P. Thiazolidinediones for the prevention of diabetes in the non-obese diabetic (NOD) mouse:implications for human type 1 diabetes. Diabetes Metab Res Rev, 2002, 18:114-117 被引量:1
  • 10胡远峰.胰岛素依赖型糖尿病的早期防治[J].中华内分泌代谢杂志,1997,13(2):67-68. 被引量:10

共引文献125

同被引文献13

引证文献1

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部